At close: December 11 at 4:00:02 PM EST
After hours: 7:16:33 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
742,527.00
669,765.00
598,112.00
540,798.00
393,719.00
Cost of Revenue
331,753.00
304,541.00
257,050.00
223,049.00
161,784.00
Gross Profit
410,774.00
365,224.00
341,062.00
317,749.00
231,935.00
Operating Expense
453,039.00
437,220.00
452,265.00
461,410.00
287,567.00
Operating Income
-42,265.00
-71,996.00
-111,203.00
-143,661.00
-55,632.00
Net Non Operating Interest Income Expense
10,382.00
9,232.00
1,307.00
-347.00
-97.00
Pretax Income
-31,883.00
-62,764.00
-109,896.00
-144,008.00
-55,729.00
Tax Provision
677.00
433.00
497.00
263.00
190.00
Net Income Common Stockholders
-32,560.00
-63,197.00
-110,393.00
-157,408.00
-55,919.00
Diluted NI Available to Com Stockholders
-32,560.00
-63,197.00
-110,393.00
-157,408.00
-55,919.00
Basic EPS
-0.27
-0.54
-0.96
-2.21
-5.02
Diluted EPS
-0.27
-0.54
-0.96
-2.21
-5.02
Basic Average Shares
119,673.66
117,389.01
114,942.02
71,249.26
11,150.00
Diluted Average Shares
119,673.66
117,389.01
114,942.02
71,249.26
11,150.00
Total Operating Income as Reported
-42,265.00
-71,996.00
-111,203.00
-143,661.00
-55,632.00
Total Expenses
784,792.00
741,761.00
709,315.00
684,459.00
449,351.00
Net Income from Continuing & Discontinued Operation
-32,560.00
-63,197.00
-110,393.00
-144,271.00
-55,919.00
Normalized Income
-32,560.00
-63,197.00
-110,393.00
-144,271.00
-55,919.00
Net Interest Income
10,382.00
9,232.00
1,307.00
-347.00
-97.00
EBIT
-42,265.00
-71,996.00
-111,203.00
-143,661.00
-55,632.00
EBITDA
1,638.00
-33,442.00
-79,339.00
-122,110.00
-37,869.00
Reconciled Cost of Revenue
331,753.00
304,541.00
257,050.00
223,049.00
161,784.00
Reconciled Depreciation
43,903.00
38,554.00
31,864.00
21,551.00
17,763.00
Net Income from Continuing Operation Net Minority Interest
-32,560.00
-63,197.00
-110,393.00
-144,271.00
-55,919.00
Normalized EBITDA
1,638.00
-33,442.00
-79,339.00
-122,110.00
-37,869.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
12/31/2020 - 9/29/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
STAA STAAR Surgical Company
25.25
-4.50%
RGEN Repligen Corporation
155.25
+2.18%
XRAY DENTSPLY SIRONA Inc.
20.03
+2.46%
PDEX Pro-Dex, Inc.
48.19
-3.04%
BDX Becton, Dickinson and Company
221.04
-0.18%
BLCO Bausch + Lomb Corporation
18.16
-12.06%
ANGO AngioDynamics, Inc.
9.11
+2.47%
NVST Envista Holdings Corporation
20.52
+2.65%
AVTR Avantor, Inc.
22.66
+0.98%
HOLX Hologic, Inc.
75.53
-1.69%